Nogo B receptor Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85390
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human Nogo B receptor. Peptide sequence: SRLMDEILKQQQELLGLDCSKYSPEFANSNDKDDQVLNCHLAVKVLSPED The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Nogo B receptor Antibody
![Western Blot: Nogo B receptor Antibody [NBP2-85390]](https://resources.bio-techne.com/images/products/Nogo-B-receptor-Antibody-Western-Blot-NBP2-85390-img0001.jpg "Western Blot: Nogo B receptor Antibody [NBP2-85390]")
Western Blot: Nogo B receptor Antibody [NBP2-85390]
Western Blot: Nogo B receptor Antibody [NBP2-85390] - Host: Rabbit. Target Name: NUS1. Sample Tissue: Human 293T Whole Cell lysates. Antibody Dilution: 1ug/mlApplications for Nogo B receptor Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Nogo B receptor
Alternate Names
C6orf68MGC117249, chromosome 6 open reading frame 68, MGC:7199, MGC7199, NgBR, nogo-B receptor, Nuclear undecaprenyl pyrophosphate synthase 1 homolog, nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)
Gene Symbol
NUS1
Additional Nogo B receptor Products
Product Specific Notices for Nogo B receptor Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...